Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06625593
What this trial is testing

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 168
Not applicableTemporarily pausedNCT03193073
What this trial is testing

Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

Who this might be right for
Anemia of Chronic Kidney DiseaseEndothelial DysfunctionLeft Ventricular Hypertrophy+1 more
Omnia Mohammed Hashem 80
Not applicableUnknownNCT06435741
What this trial is testing

Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.

Who this might be right for
Stomach NeoplasmLymph Node MetastasisRADIONUCLIDE IMAGING
Peking University Cancer Hospital & Institute 30
Early research (Phase 1)Study completedNCT01928459
What this trial is testing

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT01115634
What this trial is testing

Autologous Fibroblast Transplantation in Facial Deformities

Who this might be right for
Nasolabial FoldsGlabellar CreaseDeep Wrinkles of the Forehead+1 more
Royan Institute 60
Large-scale testing (Phase 3)Study completedNCT05052801
What this trial is testing

Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 547
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Not applicableUnknownNCT03322306
What this trial is testing

Establishment of Genetic Basis for Neurological Disease by Genetic Screening

Who this might be right for
Neuro-Degenerative Disease
Chinese University of Hong Kong 200
Testing effectiveness (Phase 2)Ended earlyNCT03510455
What this trial is testing

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

Who this might be right for
Tumor-Induced OsteomalaciaOncogenic Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 4
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Not applicableStudy completedNCT06614062
What this trial is testing

Clinical Study of 18F-FAPI-RGD in Ovarian Cancer

Who this might be right for
Observational
Sichuan Provincial People's Hospital 30
Not applicableEnded earlyNCT02926963
What this trial is testing

Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.

Who this might be right for
Chronic Granulomatous Disease
University Hospital, Grenoble 3
Not applicableUnknownNCT05637034
What this trial is testing

68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer

Who this might be right for
Tumor, Solid
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01732107
What this trial is testing

Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression

Who this might be right for
Bladder Cancer
Noah Hahn, M.D. 13
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Early research (Phase 1)Study completedNCT02404870
What this trial is testing

Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 67
Not applicableStudy completedNCT01547962
What this trial is testing

A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva

Who this might be right for
Gingival Recession
Organogenesis 25
Not applicableStudy completedNCT01917591
What this trial is testing

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Who this might be right for
Punch Biopsy WoundsHealing Times
Kerecis Ltd. 81
Not applicableStudy completedNCT05275491
What this trial is testing

Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients

Who this might be right for
COVID-19
Aswan University Hospital 66
Early research (Phase 1)Study completedNCT01868022
What this trial is testing

Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling

Who this might be right for
Neoplasms
GlaxoSmithKline 65
Next Page